Skip to content
GenoLensGenoLens

ARHGEF9

Chr Xq11.1

Cdc42 guanine nucleotide exchange factor 9

Aliases:
KIAA0424, PEM-2
MANE:
ENST00000671741.2

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)
  • Early onset or syndromic epilepsy

    X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)
  • Intellectual disability

    X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)

Disease associations (Open Targets)

  • developmental and epileptic encephalopathy, 8

    0.80
  • Hyperekplexia - epilepsy

    0.60
  • hereditary disease

    0.53
  • X-linked intellectual disability - epilepsy

    0.52
  • X-linked complex neurodevelopmental disorder

    0.37
  • Global developmental delay

    0.34
  • Seizure

    0.34
  • developmental disability

    0.34
  • Neurodevelopmental delay

    0.27
  • alopecia

    0.24

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Rho guanine nucleotide exchange factor 9

Acts as a guanine nucleotide exchange factor (GEF) for CDC42. Promotes formation of GPHN clusters (By similarity)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.